The CR rates for nausea (76.85% versus 44.44%) and vomiting (85.95% versus 67.59%) were also significantly higher in the olanzapine group for the 5 days post-chemotherapy. After chemotherapy, global health status, emotional functioning, and insomnia were improved in the olanzapine group but ...
Olanzapine for intractable nausea and vomiting in palliative care patients not receiving chemotherapy 机译:奥氮平用于未接受化疗的姑息治疗患者的顽固性恶心和呕吐 获取原文 获取原文并翻译 | 示例 掌桥外文数据库(机构版) >> 开具论文收录证明 >> 文献代查 >> 页面...
Chemotherapy-induced nausea and vomiting (CINV) is associated with a significant deterioration in quality of life and is one of the reasons for the discontinuation of treatment. Olanzapine is known as an atypical antipsychotic agent, but it has been reported to be effective in treating refractory ...
The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin. The Aprepitant Protocol 052 Study Group J Clin Oncol, 21 (2003), pp. 4112-4119 ...
Chemotherapy-induced nausea and vomiting (CINV) is a significant issue for cancer patients as it can greatly affect their quality of life and can result in the delay or discontinuation of treatment. The current standard antiemetic regimen is typically an NK1-receptor antagonist (aprepitant or fosapr...
Vig S, Seibert L, Green MR (2014) Olanzapine is effective for re- fractory chemotherapy-induced nausea and vomiting irrespective of chemotherapy emetogenicity. J Cancer Res Clin Oncol 140:77-82Vig S, Seibert L, Green MR (2014). Olanzapine is effective for refractory chemotherapy-induced ...
Since olanzapine is currently administered to cancer patients for the purpose of preventing nausea and vomiting induced by chemotherapy [19], we wonder if olanzapine modulates the sensitivity of cancer cells to chemotherapeutic agents. OLZ treatment reinstated the sensitivity of LLC1 syngeneic tumor ...
Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a randomized phase III trial. BackgroundThe purpose of the study was to compare the effectiveness of olanzapine (OLN) and aprepitant (APR) for the prevention of chemotherapy-induced nau... RM Navari,SE Gr...
Olanzapine is effective in the treatment of overall and delayed chemotherapy-induced nausea and vomiting based on meta-analysis of RCTs [90,91]. Data for chronic nausea and emesis associated with gastroparesis is lacking. It is reasonable to use olanzapine for patients with nausea and emesis ...
Chemotherapy-induced nausea and vomitingAntiemeticMeta-analysisSystemic reviewOlanzapine is an anti-psychotic drug that has been used for preventing and treating Chemotherapy-Induced Nausea and Vomiting (CINV). This study aimed to systematically review and meta-analyze the efficacy and safety of olanzapine...